A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure
Background/Aims: Absolute risk of acute-on-chronic liver failure (ACLF) can be overestimated when the hazards of competing events, such as liver transplantation (LT) or death without ACLF, are not incorporated. We developed and validated a novel competing-risk-based model integrating systemic inflammation to predict ACLF development. Methods: The derivation cohort comprised 1,146 patients with acute decompensation of cirrhosis from the prospective, multicenter Korean Acute-on-Chronic Liver Failure (KACLiF) cohort. External validation used a retrospective 1,104-patient cohort. The study followed the TRIPOD+AI reporting guidelines and applied a Fine-Gray subdistribution hazard model accounting for the competing risks of death or LT, with predictive performance evaluated using the C-index and time-dependent area under the receiver operating characteristic curve (AUROC). Results: The KACLiF-ACLF score integrated C-reactive protein, albumin, total bilirubin, international normalized ratio, and creatinine. In derivation, the competing-risk C-index (0.806 at 28 days; 0.791 at 90 days) significantly exceeded all eight comparators at 90 days, but not MELD or MELD-Na at 28 days. In external validation, it (0.892 and 0.889) significantly exceeded all comparators at both horizons. Time-dependent AUROCs at 28 days were 0.815 and 0.894, significantly exceeding all comparators at both horizons except MELD-Na at 28 days in derivation. Transported absolute risks were overpredicted, requiring recalibration. The model stratified patients into low-, intermediate-, and high-risk groups, correlating with cumulative ACLF incidence and transplant-free survival (P<0.001). Conclusions: The KACLiF-ACLF score discriminates ACLF development with high accuracy in external validation and supports risk stratification within a competing-risk framework. Recalibrated absolute risks require independent validation before clinical implementation.
Authors
- Do Seon Song (ORCID: https://orcid.org/0000-0002-8278-4878)
- Ki Tae Suk (ORCID: https://orcid.org/0000-0002-9206-9245)
- Dong Hyo Hyun
- Eileen Laureal Yoon (ORCID: https://orcid.org/0000-0003-0474-048X)
- Tae Yeob Kim (ORCID: https://orcid.org/0000-0001-7978-5303)
- Soung Won Jeong (ORCID: https://orcid.org/0000-0003-2855-6011)
- Heechul Nam (ORCID: https://orcid.org/0000-0001-5421-6868)
- Sung‐Eun Kim (ORCID: https://orcid.org/0000-0003-3742-0271)
- Hee Yeon Kim (ORCID: https://orcid.org/0000-0001-9669-5705)
- Hyung Joon Yim (ORCID: https://orcid.org/0000-0001-9370-7977)
- Jung Gil Park (ORCID: https://orcid.org/0000-0001-5472-4731)
- Young Kul Jung (ORCID: https://orcid.org/0000-0002-6566-1382)
- Young Chang
- Jeong-Ju Yoo
- Jae Young Jang
- Jung-Hee Kim
- Sang Gyune Kim
- Moon Young Kim
- on behalf of the Korean Acute-on-Chronic Liver Failure (KACLiF) study group
- Won Kim
Institutions
- Seoul National University (KR)
- Hallym University (KR)
- Yonsei University (KR)
- Soonchunhyang University (KR)
- Seoul Metropolitan Government (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
- Wonju Severance Christian Hospital (KR)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- Hanyang University Seoul Hospital (KR)
- Yeungnam University Medical Center (KR)
- Yeungnam University College (KR)
- Soonchunhyang University Hospital Bucheon (KR)
- Yonsei University Mirae Campus (KR)
- Korea University Anam Hospital (KR)
- Korea University Ansan Hospital (KR)
- Hanyang University (KR)
- Yeungnam University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3350/cmh.2026.0766
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00